Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #51418 on Therapeutic Solutions International Inc (TSOI)
BigBadWolf
05/04/22 3:00 PM
#51422 RE: BigBadWolf #51418
The study will be comprised of two groups, JadiCell™ treatment group and control group. The primary endpoint of the study is comparing the proportion of patients alive and free of respiratory failure at Day 60 after treatment with JadiCells as compared to placebo.
tractor4sale
05/04/22 9:38 PM
#51425 RE: BigBadWolf #51418